Correlation Between Zentalis Pharmaceuticals and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Puma Biotechnology, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Puma Biotechnology.
Diversification Opportunities for Zentalis Pharmaceuticals and Puma Biotechnology
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Zentalis and Puma is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Puma Biotechnology
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Puma Biotechnology. In addition to that, Zentalis Pharmaceuticals is 1.2 times more volatile than Puma Biotechnology. It trades about 0.0 of its total potential returns per unit of risk. Puma Biotechnology is currently generating about 0.12 per unit of volatility. If you would invest 258.00 in Puma Biotechnology on August 28, 2024 and sell it today you would earn a total of 56.00 from holding Puma Biotechnology or generate 21.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Puma Biotechnology
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Puma Biotechnology |
Zentalis Pharmaceuticals and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Puma Biotechnology
The main advantage of trading using opposite Zentalis Pharmaceuticals and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Scpharmaceuticals | Zentalis Pharmaceuticals vs. Milestone Pharmaceuticals | Zentalis Pharmaceuticals vs. Seres Therapeutics |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |